Loading clinical trials...
Loading clinical trials...
Measurement of the Changes in Acceptability of Hepatitis B Immunization Among General Practitioners and Open-care Paediatricians
Conditions
Interventions
Data collection
Locations
402
France
GSK Investigational Site
Agde, France
GSK Investigational Site
Agen, France
GSK Investigational Site
Agen, France
GSK Investigational Site
Aire-sur-la-Lys, France
GSK Investigational Site
Aizenay, France
GSK Investigational Site
Albi, France
Start Date
November 1, 2009
Primary Completion Date
April 1, 2012
Completion Date
April 1, 2012
Last Updated
February 4, 2013
NCT07024641
NCT06671093
NCT07275554
NCT03826433
NCT06885710
NCT06947499
Lead Sponsor
GlaxoSmithKline
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions